Umbilical cord-derived mesenchymal stromal cells preserve endogenous insulin production in type 1 diabetes: a Phase I/II randomised double-blind placebo-controlled trial.
Per-Ola CarlssonDaniel EspesSofia SisayLindsay C DaviesCarl Inge Edvard SmithMathias G SvahnPublished in: Diabetologia (2023)
ClinicalTrials.gov NCT03406585 FUNDING: The sponsor of the clinical trial is NextCell Pharma AB, Stockholm, Sweden.